Clinical Trials Management System Market Size, Share & Trends Analysis Report By Solution Type, By Delivery Mode (Web & Cloud-based, On-premise), By Component (Software, Services), By End-user, By Region, And Segment Forecasts, 2024 - 2030

Clinical Trials Management System Market Size, Share & Trends Analysis Report By Solution Type, By Delivery Mode (Web & Cloud-based, On-premise), By Component (Software, Services), By End-user, By Region, And Segment Forecasts, 2024 - 2030

Clinical Trials Management System Market Growth & Trends

The global clinical trials management system market size is anticipated to reach USD 4.73 billion by 2030 and is projected to grow at a CAGR of 14.65% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing number of clinical trials, a rise in virtual or decentralized clinical trials, and the growing demand for eClinical solutions are some of the factors contributing to the market growth.

Life science companies' rising R&D investments and the prevalence of acute and chronic disorders contribute to the surge in clinical trials aimed at enhancing patient outcomes. For instance, ClinicalTrials.gov reports 653 active clinical trials on diabetes, indicating a significant demand for solutions like Clinical Trial Management (CTM) systems to efficiently manage multiple trials.

Several market players are launching tailored solutions or optimizing existing solutions to fit DCTs and their requirements. For example, the decentralized CTM Solution by Cloudbyz offers a cloud-based CTM solution that offers a range of features such as ePRO, remote monitoring & SDV, eConsent, eCRF, EDC, eCOA, eDiary, virtual PR, and eTMF to support virtual trials. As of 2022, Parexel International Corporation, a key player in the market, conducted over 250 fully virtual or hybrid DCTs and has experience with over 200 remote patient engagement strategies, e.g., patient recruitment, e-visits, and retention platforms, incorporated into trials.

Clinical Trials Management System Market Report Highlights

• The market is primarily driven by rapid growth of healthcare IT, rise in the number of clinical trials, increased adoption of CTMS solutions, and government support for clinical research in both developed & developing countries
• Based on solution type, the enterprise segment led the market with the largest revenue share of 74.35% in 2023, owing to its key benefits, such as offering end-to-end insights into deviations & accruals, robust reporting, scalability of solutions, tracking & managing regulatory processes, and enhanced billing compliance
• Based on component, the software segment led the market with the largest revenue share of 56.04% in 2023, due to it being an easy-to-use tool that helps manage clinical trials and perform critical functions
• Based on delivery mode, web & cloud segment led the market with the largest revenue share of 56.04% in 2023, due to its increased adoption by end users
• Based on end user, the CRO and others segment held the market with the largest revenue share of 40.16% in 2023, owing to the increasing number of partnerships, clinical trial outsourcing to CROs, and decentralized trial counts
• North America dominated the market with a revenue share of 50.01% in 2023, owing to the technological advancements, strong presence of market players in the regions, technological advancement in the field of clinical trials, and supportive government policies to promote clinical trials

Please note The report will be delivered in 2-3 business days upon order notification.